Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus ketofol for anesthesia during electroconvulsive therapy
IRCT20251214068324N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of propofol and ketamine in major depressive disorder (MDD), anorexia nervosa (AN), obsessive compulsive disorder (OCD) and 2 more (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Duration of seizure, Duration of anesthesia and 3 more. Started Mar 2026; status: completed.
02
Drugs
propofolketamine
03
Conditions
major depressive disorder (MDD)anorexia nervosa (AN)obsessive compulsive disorder (OCD)generalized anxiety disorder (GAD)bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20251214068324N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251214068324N1.